
1. General Information
Twinaqt 50/300 Tablet is a fixed-dose combination antiretroviral medicine containing Dolutegravir 50 mg + Lamivudine 300 mg. It is manufactured by Emcure Pharmaceuticals Ltd. and is supplied commonly in a 30-tablet bottle. Twinaqt is a prescription medicine used as part of HIV-1 treatment in appropriate adult patients.
Twinaqt combines two antiretroviral medicines with different mechanisms of action to suppress HIV replication and help reduce the amount of HIV in the blood.
Exporter Information: Phoenix Exim, Nagpur, India
Supply Markets: USA, UK, Australia, Singapore, Canada, South Korea and UAE.
2. Product Information
Product Name: Twinaqt 50/300 Tablet
Active Ingredients: Dolutegravir 50 mg + Lamivudine 300 mg
Dosage Form: Film-coated tablet
Typical Pack Size: 30 tablets
Therapeutic Category: Antiretroviral medicine
Manufacturer: Emcure Pharmaceuticals Ltd.
Route: Oral administration
Prescription: Prescription medicine
Each film-coated tablet contains lamivudine 300 mg and dolutegravir equivalent to 50 mg of dolutegravir.
3. Uses of Twinaqt 50/300 Tablet
Twinaqt is indicated for the treatment of HIV-1 infection in appropriate patients.
According to product information, the dolutegravir/lamivudine combination can be used as a complete regimen in adults who have no previous antiretroviral treatment history, or in selected adults who are already virologically suppressed on a stable regimen without treatment failure or relevant resistance to either component.
Potential treatment objectives include:
- Reducing HIV viral load
- Suppressing HIV replication
- Supporting recovery or maintenance of CD4 immune-cell levels
- Helping reduce the risk of HIV-related disease progression
- Maintaining long-term viral suppression when taken consistently as prescribed
Twinaqt should be used only according to the treatment plan established by a qualified HIV-care professional.
4. Benefits of Twinaqt
Twinaqt provides the convenience of two antiretroviral medicines in one tablet, which can simplify an appropriate HIV treatment regimen.
Key potential benefits include:
- Helps suppress HIV-1 replication
- Can reduce HIV viral load when taken consistently
- Combines two active antiretroviral agents
- Once-daily administration may simplify treatment for appropriate patients
- Helps maintain viral suppression as part of an appropriate treatment plan
- Reduces the number of separate tablets required compared with taking the two components individually
Twinaqt does not cure HIV, but effective antiretroviral treatment can suppress the virus and help people with HIV maintain better long-term health.
5. Side Effects of Twinaqt
Like other medicines, Twinaqt may cause side effects. Not everyone experiences them.
Reported or possible adverse effects include:
- Headache
- Nausea
- Diarrhoea
- Tiredness or fatigue
- Dizziness
- Sleep disturbances
- Anxiety or mood-related symptoms
- Muscle weakness
- Vomiting
- Abdominal discomfort
Some patients may experience changes in liver-related laboratory tests. Rare but serious reactions, including severe hypersensitivity reactions or significant liver problems, require prompt medical attention.
6. Common Side Effects
Some of the more commonly reported side effects include:
- Headache
- Nausea
- Diarrhoea
- Fatigue
- Difficulty sleeping
- Dizziness
- Abdominal or gastrointestinal discomfort
Many mild effects may improve as the body adjusts to treatment. Persistent, severe or worsening symptoms should be discussed with a healthcare professional.
7. How to Use Twinaqt
Twinaqt should be taken exactly as prescribed by a doctor or HIV specialist.
General administration information:
- Swallow the tablet whole with water.
- It may generally be taken with or without food, according to the prescribed regimen.
- Take it at approximately the same time each day.
- Do not crush, chew or break the tablet unless specifically instructed by a healthcare professional.
- Do not stop treatment simply because you feel well.
- If a dose is missed, follow your healthcare professional's instructions rather than taking extra tablets without advice.
The appropriate dose and duration depend on the patient's clinical circumstances, other medicines, kidney/liver function and HIV treatment history.
8. How Twinaqt Works
Twinaqt contains two antiretroviral medicines:
Dolutegravir
Dolutegravir is an integrase strand transfer inhibitor (INSTI). It blocks HIV integrase, an enzyme HIV needs to integrate its genetic material into human cells. This interferes with an important stage of HIV replication.
Lamivudine
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI). It interferes with reverse transcriptase, an enzyme HIV requires to reproduce its genetic material.
By combining these two mechanisms, Twinaqt helps inhibit HIV replication and lowers the amount of virus in the body.
9. Safety Advice for Twinaqt
Twinaqt is a prescription antiretroviral medicine and should be used under appropriate medical supervision.
Important safety considerations
- Tell your doctor about all medicines, vitamins and supplements you take.
- Inform your doctor if you have liver or kidney problems.
- Testing for hepatitis B virus (HBV) is recommended before or when starting dolutegravir/lamivudine therapy.
- Patients with hepatitis B should not discontinue therapy without medical guidance because stopping lamivudine-containing treatment can cause hepatitis B to worsen.
- Discuss pregnancy or plans to become pregnant with your healthcare provider before treatment.
- Seek urgent medical attention for signs of severe allergic reaction such as rash accompanied by fever, facial swelling, breathing difficulty or significant systemic symptoms.
- Do not share your prescription medicine with another person.
- Continue regular HIV monitoring, including viral-load testing, as recommended by your healthcare professional.
- Store the tablets according to the product label and protect them from excessive moisture.
Drug interactions
Dolutegravir can interact with certain medicines and mineral-containing products. In particular, products containing aluminium, magnesium, calcium or iron may require specific timing arrangements. Always tell your healthcare professional about antacids, supplements and other medicines you use.
10. Frequently Asked Questions (FAQs)
What is Twinaqt 50/300 Tablet?
Twinaqt 50/300 Tablet is an antiretroviral combination containing Dolutegravir 50 mg and Lamivudine 300 mg, used for appropriate HIV-1 treatment.
What is Twinaqt used for?
It is used to treat HIV-1 infection in appropriate patients as determined by a healthcare professional.
Does Twinaqt cure HIV?
No. Twinaqt does not eliminate HIV from the body. It helps suppress HIV replication and maintain viral control when used correctly.
How often is Twinaqt taken?
The combination is generally administered once daily in appropriate patients, but the exact regimen should be determined by the prescribing healthcare professional.
Can Twinaqt be stopped suddenly?
Do not stop Twinaqt without medical advice. Stopping antiretroviral therapy can allow HIV to multiply and may lead to loss of viral suppression. Special caution is required in people with hepatitis B.
Can Twinaqt be used during pregnancy?
Pregnancy decisions should be discussed with an HIV specialist or qualified healthcare professional. The benefits and risks of treatment should be evaluated individually.
Can Twinaqt be used for HIV prevention?
Twinaqt is a treatment regimen for HIV-1 infection in appropriate patients. It should not be assumed to be a suitable HIV-prevention medicine such as PrEP or PEP.
What should I do if I miss a dose?
Follow your healthcare professional's instructions. Do not routinely double the next dose unless specifically instructed.
Is Twinaqt a prescription medicine?
Yes. Twinaqt is a prescription antiretroviral medicine.
11. Substitute for Twinaqt
The appropriate substitute depends on the patient's HIV treatment history, resistance profile, kidney/liver function, hepatitis B status and other medicines.
Possible alternatives may include:
- Dolutegravir + Lamivudine from another manufacturer
- Other approved dolutegravir-based antiretroviral regimens
- Dovato (dolutegravir/lamivudine) where approved and clinically appropriate
- Other HIV combination therapies selected by an HIV specialist
A substitute should not be selected solely on the basis of matching strength or price. HIV medicines are not automatically interchangeable because resistance, previous treatment failure and co-existing hepatitis B can affect treatment selection.
12. SEO Keywords
Primary Keywords
- Twinaqt 50/300 Tablet
- Twinaqt Tablet
- Twinaqt 50 mg 300 mg
- Twinaqt Dolutegravir Lamivudine
- Dolutegravir 50 mg Lamivudine 300 mg
- Twinaqt HIV medicine
- Twinaqt antiretroviral tablet
- Twinaqt HIV treatment medicine
- Twinaqt tablets supplier
- Twinaqt tablets exporter
Long-Tail B2B / Export Keywords
- Twinaqt 50/300 Tablet exporter from India
- Twinaqt Tablet supplier from Nagpur India
- Twinaqt Dolutegravir Lamivudine exporter India
- Twinaqt 50/300 Tablet wholesale supplier India
- Twinaqt HIV medicine exporter from Nagpur
- Dolutegravir Lamivudine tablets exporter India
- Twinaqt 50/300 pharmaceutical supplier
- Twinaqt tablets international pharmaceutical exporter
- Twinaqt medicine supplier for USA
- Twinaqt medicine supplier for UK
- Twinaqt medicine exporter to Australia
- Twinaqt tablets supplier to Singapore
- Twinaqt HIV medicine supplier Canada
- Twinaqt pharmaceutical supplier South Korea
- Twinaqt antiretroviral medicine supplier UAE
- Dolutegravir 50 mg Lamivudine 300 mg exporter India
- HIV antiretroviral medicine exporter from India
- HIV treatment tablets wholesale supplier India
- prescription HIV medicine exporter India
- genuine Twinaqt 50/300 tablets supplier
Phoenix Exim SEO Keywords
- Phoenix Exim Twinaqt Tablet supplier
- Phoenix Exim Twinaqt 50/300 exporter
- Phoenix Exim HIV medicine exporter Nagpur
- Phoenix Exim antiretroviral medicine supplier India
- Twinaqt 50/300 Tablet exporter Nagpur India to USA UK Australia
- Twinaqt Dolutegravir Lamivudine supplier Nagpur India
- Phoenix Exim pharmaceutical exporter to USA UK Australia Canada
- Phoenix Exim medicine exporter to Singapore South Korea UAE
Keywords







